These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37478182)

  • 1. What is really known about the effects of nicotinamide riboside supplementation in humans.
    Damgaard MV; Treebak JT
    Sci Adv; 2023 Jul; 9(29):eadi4862. PubMed ID: 37478182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NAD(+) precursor nicotinamide riboside decreases exercise performance in rats.
    Kourtzidis IA; Stoupas AT; Gioris IS; Veskoukis AS; Margaritelis NV; Tsantarliotou M; Taitzoglou I; Vrabas IS; Paschalis V; Kyparos A; Nikolaidis MG
    J Int Soc Sports Nutr; 2016; 13():32. PubMed ID: 27489522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can nicotinamide riboside protect against cognitive impairment?
    Braidy N; Liu Y
    Curr Opin Clin Nutr Metab Care; 2020 Nov; 23(6):413-420. PubMed ID: 32925178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition.
    Bogan KL; Brenner C
    Annu Rev Nutr; 2008; 28():115-30. PubMed ID: 18429699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy.
    Diguet N; Trammell SAJ; Tannous C; Deloux R; Piquereau J; Mougenot N; Gouge A; Gressette M; Manoury B; Blanc J; Breton M; Decaux JF; Lavery GG; Baczkó I; Zoll J; Garnier A; Li Z; Brenner C; Mericskay M
    Circulation; 2018 May; 137(21):2256-2273. PubMed ID: 29217642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purine nucleoside phosphorylase controls nicotinamide riboside metabolism in mammalian cells.
    Kropotov A; Kulikova V; Solovjeva L; Yakimov A; Nerinovski K; Svetlova M; Sudnitsyna J; Plusnina A; Antipova M; Khodorkovskiy M; Migaud ME; Gambaryan S; Ziegler M; Nikiforov A
    J Biol Chem; 2022 Dec; 298(12):102615. PubMed ID: 36265580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide Riboside-The Current State of Research and Therapeutic Uses.
    Mehmel M; Jovanović N; Spitz U
    Nutrients; 2020 May; 12(6):. PubMed ID: 32486488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balancing NAD
    Cercillieux A; Ciarlo E; Canto C
    Cell Mol Life Sci; 2022 Aug; 79(8):463. PubMed ID: 35918544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.
    Freeberg KA; Udovich CC; Martens CR; Seals DR; Craighead DH
    J Gerontol A Biol Sci Med Sci; 2023 Dec; 78(12):2435-2448. PubMed ID: 37068054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide, Nicotinamide Riboside and Nicotinic Acid-Emerging Roles in Replicative and Chronological Aging in Yeast.
    Orlandi I; Alberghina L; Vai M
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of NAD
    Metcalfe M; David BT; Langley BC; Hill CE
    Exp Neurol; 2023 Oct; 368():114479. PubMed ID: 37454712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.
    Brakedal B; Dölle C; Riemer F; Ma Y; Nido GS; Skeie GO; Craven AR; Schwarzlmüller T; Brekke N; Diab J; Sverkeli L; Skjeie V; Varhaug K; Tysnes OB; Peng S; Haugarvoll K; Ziegler M; Grüner R; Eidelberg D; Tzoulis C
    Cell Metab; 2022 Mar; 34(3):396-407.e6. PubMed ID: 35235774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction.
    Kahn B; Borrelli M; Libby T
    J Drugs Dermatol; 2022 Oct; 21(10):1129-1132. PubMed ID: 36219044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
    Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
    Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma.
    Goulart Nacácio E Silva S; Occhiutto ML; Costa VP
    Eur J Ophthalmol; 2023 Sep; 33(5):1801-1815. PubMed ID: 36916064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Role of Nicotinamide Riboside in Health and Diseases.
    Sharma C; Donu D; Cen Y
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan.
    Sharma A; Chabloz S; Lapides RA; Roider E; Ewald CY
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection.
    Chi Y; Sauve AA
    Curr Opin Clin Nutr Metab Care; 2013 Nov; 16(6):657-61. PubMed ID: 24071780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide Riboside for the Prevention and Treatment of Doxorubicin Cardiomyopathy. Opportunities and Prospects.
    Podyacheva E; Toropova Y
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+.
    Belenky P; Racette FG; Bogan KL; McClure JM; Smith JS; Brenner C
    Cell; 2007 May; 129(3):473-84. PubMed ID: 17482543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.